Tamiflu Dosing for an 18-Month-Old Child
For an 18-month-old child, administer oseltamivir 30 mg twice daily for 5 days if the child weighs ≤15 kg (≤33 lb), or 45 mg twice daily if the child weighs >15-23 kg (33-51 lb), using the oral suspension formulation (6 mg/mL concentration). 1, 2
Weight-Based Dosing Algorithm
At 18 months of age, children fall into the ≥12 months category and require weight-based dosing rather than age-based dosing:
- If weight ≤15 kg (≤33 lb): 30 mg twice daily = 5 mL of oral suspension twice daily for 5 days 1, 2
- If weight >15-23 kg (33-51 lb): 45 mg twice daily = 7.5 mL of oral suspension twice daily for 5 days 1, 2
- If weight >23-40 kg (51-88 lb): 60 mg twice daily = 10 mL of oral suspension twice daily for 5 days 1, 2
The most critical step is to verify the child's current weight before prescribing to avoid dosing errors. 3
Formulation and Administration
- Use the oral suspension formulation (6 mg/mL concentration after reconstitution by the pharmacist) 1, 2
- Administer with food to improve gastrointestinal tolerability, as nausea and vomiting are common adverse effects 1, 4
- Use an accurate oral dosing syringe or measuring device to ensure precise volume measurement 2
Critical Timing Considerations
Treatment must be initiated within 48 hours of symptom onset for maximum effectiveness. 4, 5, 2 Earlier initiation is associated with faster symptom resolution and better clinical outcomes 6
Common Pitfalls to Avoid
- Do not use age-based dosing (3 mg/kg) for children ≥12 months old - this dosing is reserved for infants <12 months 1, 2
- Do not assume weight - always verify current weight as children at 18 months can vary significantly in size 3
- Do not delay treatment waiting for laboratory confirmation in high-risk patients or those with severe symptoms 4
Prophylaxis Dosing (If Needed)
For post-exposure prophylaxis following close contact with an infected individual:
- Same weight-based doses as treatment, but given once daily instead of twice daily for 10 days 1, 2
- Must be initiated within 48 hours of exposure 2
Special Considerations
- No renal dose adjustment needed unless the child has moderate to severe renal impairment (creatinine clearance 10-30 mL/min), in which case reduce to once daily dosing 1, 4
- The standard 5-day treatment duration applies regardless of weight category 1, 3
- Oseltamivir is FDA-approved for treatment in children as young as 2 weeks of age 1, 5, 2